FDA NDC Directory · JSON-LD · Markdown

Desonide

NDC 45802-423 · HUMAN PRESCRIPTION DRUG · OINTMENT

Labeler / ManufacturerPadagis Israel Pharmaceuticals Ltd
Marketing categoryNew Drug Application (innovator) · App NDA017426
Dosage form / routeOINTMENT · TOPICAL
Active ingredientsDESONIDE (.5 mg/g)
Marketing started20060822
Package count2

External sources

Source: openFDA. Public-domain (CC0).